SWAG Cancer Alliance questionnaire for faster diagnosis in Rare and Less Common Cancers
As a patient representative in Somerset, Wiltshire, Avon, and Gloucestershire (SWAG) NHS Cancer Alliance Faster Diagnosis Steering Group, my role is to assist the SWAG faster diagnosis group by representing the patient view. I have a Neuroendocrine cancer diagnosed in stage 4.
The NHS aims to diagnose cancers as early as possible before they spread. NHS England are committed to rolling out Faster Diagnosis pathways as part of the NHS Long Term Plan to deliver fast and earlier diagnosis and improved patient experience. The number of people diagnosed with cancer has been rising in recent years, with a 29% increase expected between 2016-2028. To ensure we maintain standards, whilst providing a diagnosis to more people, we will need to transform the way we deliver diagnostic services, including diagnostics for cancer. Faster Diagnosis pathways will support the new 28 day Faster Diagnosis Standard (FDS) and assist Primary Care Networks to improve early diagnosis in their localities. For more information please see link NHS England » Faster diagnosis
The questionnaire below is aimed at assisting the development of the SWAG faster diagnosis programme so when GPs refer, rare and less common cancers are included. We hope that this will encourage GPs to refer when they have a suspicion cancer may be present.
The most common types of cancer in the UK make up 53% of all cancer diagnosed and include breast cancer in women, prostate cancer, lung cancer, and bowel cancer. Less common cancers make up 27% of cancers such as melanoma and bladder cancer. About 20% of people (1 in 5) have a rare cancer and 1 in 3 of those rare cancers are very rare (fewer than 1 in 100,000 people every year). Rare cancers - Macmillan Cancer Support(External link)
Given that as many as 47% of UK cancers are rare and less common, we hope your perspectives can help us design a service that meets the needs of people with rare and less common cancers.
Robert Page
As a patient representative in Somerset, Wiltshire, Avon, and Gloucestershire (SWAG) NHS Cancer Alliance Faster Diagnosis Steering Group, my role is to assist the SWAG faster diagnosis group by representing the patient view. I have a Neuroendocrine cancer diagnosed in stage 4.
The NHS aims to diagnose cancers as early as possible before they spread. NHS England are committed to rolling out Faster Diagnosis pathways as part of the NHS Long Term Plan to deliver fast and earlier diagnosis and improved patient experience. The number of people diagnosed with cancer has been rising in recent years, with a 29% increase expected between 2016-2028. To ensure we maintain standards, whilst providing a diagnosis to more people, we will need to transform the way we deliver diagnostic services, including diagnostics for cancer. Faster Diagnosis pathways will support the new 28 day Faster Diagnosis Standard (FDS) and assist Primary Care Networks to improve early diagnosis in their localities. For more information please see link NHS England » Faster diagnosis
The questionnaire below is aimed at assisting the development of the SWAG faster diagnosis programme so when GPs refer, rare and less common cancers are included. We hope that this will encourage GPs to refer when they have a suspicion cancer may be present.
The most common types of cancer in the UK make up 53% of all cancer diagnosed and include breast cancer in women, prostate cancer, lung cancer, and bowel cancer. Less common cancers make up 27% of cancers such as melanoma and bladder cancer. About 20% of people (1 in 5) have a rare cancer and 1 in 3 of those rare cancers are very rare (fewer than 1 in 100,000 people every year). Rare cancers - Macmillan Cancer Support(External link)
Given that as many as 47% of UK cancers are rare and less common, we hope your perspectives can help us design a service that meets the needs of people with rare and less common cancers.
